

Spirulina platensis, Spirulina fusiformis, AFA-algae, Arthrospira platensis, tecuitlatl, BGA, dihe
Blue-green algae are primitive autotrophic prokaryotes (aka Cyanobacteria). Spirulina species are cultured in alkaline fresh water while Aphanizomenon flos aquae (AFA) is naturally grown and harvested from Upper Klamath Lake, Oregon, USA. Blue-green algae products frequently contain one or both of these strains of algae. Patients take blue-green algae supplements to prevent and treat cancer and viral infections, and for weight loss. A cholesterol-lowering effect was found in patients with nephrotic syndrome induced hyperlipidemia. Blue-green algae are used a source of food in parts of the world. Although no human clinical data support its use for any of the proposed claims, studies suggested spirulina has chemoprotective and radioprotective effects in animals. Blue-green algae may be contaminated by strains of algae (e.g. microcystin species) that are toxic. Adverse effects are uncommon except when products are contaminated; contaminant toxins can cause hepatotoxicity, renal failure, and neurotoxicity. To date, there are no known drug interactions. Supplementation with blue-green algae provides protein and small amounts of vitamins and minerals, but no research supports their value.
The mechanism of action is unknown. The protein and vitamin content may contribute to any alleviation of fatigue. Calcium spirulan, a polysaccharide extract from Spirulina platensis, demonstrates inhibition of HIV-1 viral replication via possible binding and disruption of CD4-gp120 interaction in vitro, although the clinical significance of this is unknown. In vitro, calcium spirulan also inhibits replication of herpes simplex I, cytomegalovirus, and influenza. Studies performed in healthy humans suggest that AFA-algae increase the level of circulating natural killer cells. In vitro studies also suggest that AFA-algae has antiviral and antimutagenic activity. Other studies suggested spirulina has chemoprotective and radioprotective effects in animals through the stimulation of the hemopoietic system. Although uncommon, several toxins from Microcystis species of algae may contaminate AFA-algae and Spirulina algae blooms. Anatoxin can cause paralysis of respiratory muscles due to irreversible binding and sustained action of the nicotinic acetylcholine receptor. Saxitoxin contamination is thought to block nerve cell neuronal transmission due to binding to voltage-gated sodium channels. Microcystins are cyclic heptapeptides that induce hepatotoxicity.
(1) (2) (3) (4) (5) (6) (7) (8)
Microcystin contamination can cause hepatotoxicity, renal failure, and neurotoxicity. Products should be certified free from contamination.
Selmi C, et al. The effects of Spirulina on anemia and immune function in senior citizens. Cell Mol Immunol. 2011 Jan 31.
This study enrolled 40 volunteers, aged 50 years or older, who had been diagnosed with anemia within the previous 12 months. Participants took a Spirulina supplement and completed a nutritional questionnaire for 12 weeks. Complete cell count (CCC) and indoleamine 2,3-dioxygenase (IDO) enzyme activity were measured at baseline and weeks 6 and 12. Over the 12-week study period, there was a steady increase in average values of mean corpuscular hemoglobin (MCH) in the subjects of both genders who completed the study (n=30). The increases in MCH, mean corpuscular hemoglobin volume, and mean corpuscular hemoglobin concentration were found to be statistically significant (p<0.05) for male participants. Over 50% of subjects also achieved increased IDO activity and WBC count at 6 and 12 weeks of Soirulina supplementation. No significant changes in dietary intake were found to have occurred during the study period. The investigators concluded that spirulina may improve anemia and immunosenescence in older subjects, however larger, randomized clinical trials are necessary to confirm these benefits.
Kalafati M, et a;. Ergogenic and antioxidant effects of spirulina supplementation in humans. Med Sci Sports Exerc. 2010 Jan;42(1):142-51.
This double-blind, placebo-controlled, counterbalanced crossover study enrolled moderately conditioned male subjects (n=9) to investigate the effect of spirulina on exercise performance, substrate metabolism, and blood redox status at rest and after exercise. After taking a spirulina supplement daily for 4 weeks, each subject ran on a treadmill at an intensity corresponding to 70-75% of their V02 max for 2 hours, and then at 95% VO2 max until exhaustion. Blood samples were drawn at baseline, immediately after, and at 1, 24, and 48 hours post-exercise. Time to fatigue following the 2 hour run was found to be significantly longer after spirulina supplementation compared to placebo (2.05 + 0.68 vs 2.70 + 0.79 min; p=0.048). During the 2 hour run, spirulina supplementation also decreased carbohydrate oxidation rate by 10.3% (p=0.008) and increased fat oxidation rate by 10.9% (p=0.003), as compared to placebo (p<0.05). Reduced glutathione levels were also significantly higher after spirulina supplementation than after placebo, at rest and 24 hours after exercise (p=0.049). The authors concluded that spirulina supplementation significantly increased exercise performance, fat oxidation, and GSH concentration and reduced exercise-induced lipid peroxidation.
Lee EH. et al. A randomized study to establish the effects of spirulina in type 2 diabetes mellitus patients. Nutr Res Pract. 2008 Winter;2(4):295-300.
This randomized, placebo-controlled study enrolled 37 Korean patients with Type 2 diabetes. Patients received spirulina or placebo for 12 weeks. Spirulina supplementatiion for 12 weeks was found to significantly lower plasma triglyceride (TG) (p<0.05) and malondialdehyde levels (p<0.05), and also showed a tendency to increase plasma adiponectin levels (p<0.1). The lipid lowering effect of spirulina supplementation differed according to the subject serum levels prior to intervention. Subjects with higher initial TG levels had a greater reduction in plasma TG levels and blood pressure. Subjects with higher initial total cholesterol and LDL-cholesterol levels had a greater reduction in these values, as well as in IL-6 and blood pressure. The authors concluded that these results provide evidence that spirulina has a beneficial effect on blood lipid profiles, inflammatory variables, and antioxidant capacity in patients with type 2 diabetes.
Cingi C, et al. The effects of spirulina on allergic rhinitis. Eur Arch Otorhinolaryngol. 2008 Oct;265(10):1219-23.
This randomized, double-blind, placebo controlled-study, evaluated the effectiveness and tolerability of spirulina in the treatment of patients with a history of allergic rhinitis (n=150). Of the patients who completed the study (n=129), patients received either spirulina tablets (n=85) or placebo (n=44). Symptoms (nasal discharge, sneezing, nasal congestion, and itching) were assessed and scored on a four point scale at baseline and at study end. Patients also used a four point scale to grade the severity of their own symptoms. Satisfaction and symptom relief were also graded on a ten point scale by the patients. Spirulina supplementation was found to significantly improve allergic rhinitis symptoms compared to placebo (p<0.001). Patient diaries also revealed a statistically significant difference in effectiveness (p<0.001) and satisfaction (p<0.001) for spirulina compared to placebo. The investigators concluded that spirulina is clinically effective for the treatment of allergic rhinitis, but further studies should be performed to confirm the mechanism of this effect.
Bottom Line: Blue-green algae may contain nutrients and vitamins, but it is NOT an effective treatment for cancer, HIV, attention deficit hyperactivity disorder (ADHD), or other serious medical conditions.
Scientists do not know how blue-green algae supplements might work, since limited research has been performed. Blue-green algae are a natural source of protein and vitamins, which might contribute to alleviation of fatigue. Blue-green algae products usually contain either AFA-algae (Aphanizomenon flos aquae) or Spirulina species, or both. Both may have biological activities. In laboratory experiments, calcium spirulan, an extract from Spirulina, inhibits the replication of HIV virus, herpes simplex virus, cytomegalovirus, and influenza virus in the test tube, but it is not known whether any of these anti-viral effects would occur in the human body. Other studies showed that spirulina protected lab animals from genetic mutations caused by chemicals and radiation, but again, it is unclear whether these effects happen in humans. In healthy humans, AFA-algae appear to increase blood levels of natural killer cells (a type of immune cell). AFA-algae also show anti-viral and anti-mutation activity in the laboratory.
Spirulina algae also contain high levels of gamma-linolenic acid (GLA), an essential fatty acid that is often able to prevent the accumulation of cholesterol in the body.
Anemia
This study enrolled 40 volunteers, aged 50 years or older, who had been anemia within the previous 12 months. Participants took a Spirulina supplement and completed a nutritional questionnaire for 12 weeks. Complete cell count (CCC) and indoleamine 2,3-dioxygenase (IDO) enzyme activity were measured at baseline and weeks 6 and 12. Over the 12-week study period, there was a steady increase in average values of mean corpuscular hemoglobin (MCH) in the subjects. The increases in MCH, mean corpuscular hemoglobin volume, and mean corpuscular hemoglobin concentration were found to be statistically significant for male participants. No significant changes in dietary intake were found to have occurred during the study period. The investigators concluded that spirulina may improve anemia and immunosenescence in older subjects.
Exercise performance
This double-blind, placebo-controlled, counterbalanced crossover study enrolled moderately conditioned 9 male subjects to investigate the effect of spirulina on exercise performance, substrate metabolism, and blood redox status at rest and after exercise. After taking a spirulina supplement daily for 4 weeks, each subject ran on a treadmill at an intensity corresponding to 70-75% of their V02 max for 2 hours, and then at 95% VO2 max until exhaustion. Blood samples were drawn at baseline, immediately after, and at 1, 24, and 48 hours post-exercise. Time to fatigue following the 2 hour run was found to be significantly longer after spirulina supplementation compared to placebo. During the 2 hour run, spirulina supplementation also decreased carbohydrate oxidation and increased fat oxidation rate compared to placebo. Reduced glutathione levels were also significantly higher after spirulina supplementation than after placebo, at rest and 24 hours after exercise. The authors concluded that spirulina supplementation significantly increased exercise performance, fat oxidation, and GSH concentration and reduced exercise-induced lipid peroxidation.
Diabetes mellitus
This randomized, placebo-controlled study enrolled 37 Korean patients with Type 2 diabetes. Patients received spirulina or placebo for 12 weeks. Spirulina supplementatiion for 12 weeks was found to significantly lower plasma triglyceride (TG) and malondialdehyde levels, and also showed a tendency to increase plasma adiponectin levels. The lipid lowering effect of spirulina supplementation differed according to the subject serum levels prior to intervention. Subjects with higher initial TG levels had a greater reduction in plasma TG levels and blood pressure. Subjects with higher initial total cholesterol and LDL-cholesterol levels had a greater reduction in these values, as well as in IL-6 and blood pressure. The authors concluded that spirulina has a beneficial effect on blood lipid profiles, inflammatory variables, and antioxidant capacity in patients with type 2 diabetes.
Allergic rhinitis
This randomized, double-blind, placebo controlled-study, evaluated the effectiveness and tolerability of spirulina in the treatment of 150 patients with a history of allergic rhinitis. Patients received either spirulina tablets or placebo. Symptoms (nasal discharge, sneezing, nasal congestion, and itching) were assessed and scored on a four point scale at baseline and at study end. Patients also used a four point scale to grade the severity of their own symptoms. Satisfaction and symptom relief were also graded on a ten point scale by the patients. Spirulina supplementation was found to significantly improve allergic rhinitis symptoms compared to placebo. Patient diaries also revealed a statistically significant difference in effectiveness and satisfaction for spirulina compared to placebo. The investigators concluded that spirulina is clinically effective for the treatment of allergic rhinitis.
Blue-green algae are used a source of food in parts of the world. Consumption of this product appears to be relatively safe, as long as it is not contaminated with Microcystin species.